Published in Nephron on January 01, 1986
Cryoglobulins. J Clin Pathol (2002) 1.85
Mixed cryoglobulinemia. Orphanet J Rare Dis (2008) 1.52
Autoantibodies from mixed cryoglobulinaemia patients bind glomerular antigens. Clin Exp Immunol (1994) 0.80
Benefits and limitations of plasmapheresis in renal diseases: an evidence-based approach. J Artif Organs (2010) 0.78
Interferon alfa-2b in mixed cryoglobulinaemia: a controlled crossover trial. Gut (1993) 0.77
Symptomatic and virological response to antiviral therapy in hepatitis C associated with extrahepatic complications of cryoglobulimia. Dig Dis Sci (2007) 0.76
A trial of complement inhibition in a patient with cryoglobulin-induced glomerulonephritis. Case Rep Nephrol Urol (2012) 0.76
Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis (2002) 20.48
Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum (1993) 7.14
The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum (1996) 6.88
Association between polyarteritis and Australia antigen. Lancet (1970) 4.32
Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis (1996) 3.68
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis (2007) 3.32
New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci U S A (1998) 3.14
Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database. Ann Rheum Dis (2009) 2.61
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis (2008) 2.55
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis (2010) 2.52
European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis (2001) 2.49
Association between hepatitis C virus and mixed cryoglobulinemia [see comment]. Clin Exp Rheumatol (1992) 2.43
Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis (2006) 2.24
Exacerbation of peripheral neuropathy during alpha-interferon therapy in a patient with mixed cryoglobulinemia and hepatitis B virus infection. J Rheumatol (1996) 2.11
Murine monoclonal anti-DNA antibodies bind directly to glomerular antigens and form immune deposits. J Immunol (1987) 2.09
Plasma endothelin-1 levels, pulmonary hypertension, and lung fibrosis in patients with systemic sclerosis. Am J Med (1995) 2.07
The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome. Ann Rheum Dis (1994) 2.03
Misdiagnosis in fibromyalgia: a multicentre study. Clin Exp Rheumatol (2012) 2.02
Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism. Ann Neurol (2000) 1.99
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum (2012) 1.96
Assessment of disease severity and prognosis. Clin Exp Rheumatol (2003) 1.86
Undifferentiated connective tissue diseases: the clinical and serological profiles of 91 patients followed for at least 1 year. Lupus (1998) 1.79
Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain? J Neuroimmunol (2000) 1.76
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis (2009) 1.69
Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol (1999) 1.68
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Arthritis Rheum (2008) 1.66
Altered adrenal sensitivity to angiotensin II in low-renin essential hypertension. Hypertension (1999) 1.64
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. Rheumatology (Oxford) (2002) 1.61
Enhanced activity of sodium-lithium countertransport in patients with cardiac syndrome X: a potential link between cardiac and metabolic syndrome X. J Am Coll Cardiol (1998) 1.51
Alpha-enolase is a renal-specific antigen associated with kidney involvement in mixed cryoglobulinemia. Clin Exp Rheumatol (1998) 1.50
Prevalence of anticardiolipin antibodies in coronary artery disease. Am J Cardiol (1990) 1.49
Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum (1991) 1.49
Shrinking lung in primary Sjögren's syndrome. Arthritis Rheum (1999) 1.47
Anti-Sm and anti-RNP antibodies. Autoimmunity (2005) 1.43
Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin Exp Rheumatol (2007) 1.41
Vasculitis in association with Australia antigen. J Exp Med (1971) 1.40
Neuropsychiatric questionnaires in systemic lupus erythematosus. Clin Exp Rheumatol (2014) 1.38
A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population. Ann Rheum Dis (2004) 1.36
Plasma endothelin-1 levels in patients with systemic sclerosis: influence of pulmonary or systemic arterial hypertension. Ann Rheum Dis (1995) 1.34
European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria. Ann Rheum Dis (2003) 1.32
Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood (1993) 1.29
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis (2008) 1.28
Autoantibodies specific for alpha-enolase in systemic autoimmune disorders. J Rheumatol (2000) 1.27
Polyreactive autoantibodies are nephritogenic in murine lupus nephritis. J Immunol (1987) 1.27
Ultrasound imaging for the rheumatologist. XXV. Sonographic assessment of the knee in patients with gout and calcium pyrophosphate deposition disease. Clin Exp Rheumatol (2010) 1.21
Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med (1996) 1.18
The synovial prostaglandin system in chronic inflammatory arthritis: differential effects of steroidal and nonsteroidal anti-inflammatory drugs. Br J Pharmacol (1981) 1.15
A lupus-like syndrome in a patient with deficiency of the sixth component of complement. Arthritis Rheum (1981) 1.14
An evaluation of an agar gel diffusion test with crude and purified antigens in the diagnosis of hydatid disease. Bull World Health Organ (1974) 1.11
In vitro delayed hypersensitivity in normal and hyporeactive patients. Immunology (1971) 1.11
Churg-Strauss syndrome: clinical and serological features of 19 patients from a single Italian centre. Rheumatology (Oxford) (2002) 1.11
Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo. Circulation (1999) 1.11
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. Arthritis Rheum (2009) 1.10
Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT). Rheumatology (Oxford) (2001) 1.10
Hepatitis C virus antibodies in mixed cryoglobulinemia. Clin Exp Rheumatol (1991) 1.09
The link between pain patient and analgesic medication is greater in migraine than in rheumatic disease patients. Cephalalgia (2008) 1.09
Hepatitis C virus and mixed cryoglobulinaemia. Eur J Clin Invest (1993) 1.09
Parallel sets of autoantibodies in MRL-lpr/lpr mice. An anti-DNA, anti-SmRNP, anti-gp70 network. J Exp Med (1987) 1.08
Renal biopsy: technical notes. Nephron (1996) 1.08
Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I. Eur J Immunol (1993) 1.08
T(14;18) translocation in chronic hepatitis C virus infection. Hepatology (2000) 1.08
An enzymatically active antigen-antibody probe to measure circulating immune complexes by competition. I. Use of Escherichia coli beta-galactosidase in the probe and of bovine conglutinin as the complex-binding reagent. Clin Immunol Immunopathol (1980) 1.07
A technique for immunoassay of human IgG. Proc Soc Exp Biol Med (1970) 1.07
Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation. Rheumatology (Oxford) (1999) 1.06
Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus. J Clin Invest (1985) 1.06
Lung involvement in Sjögren's syndrome: a comparison between patients with primary and with secondary syndrome. Ann Rheum Dis (1985) 1.06
T cell immunoregulation in rheumatoid synovitis. Arthritis Rheum (1988) 1.05
Cutaneous and serologic subsets of systemic sclerosis. J Rheumatol (1991) 1.05
Sarcomatoid carcinoma of the kidney. J Urol (1987) 1.04
Undifferentiated connective tissue diseases (UCTD). Autoimmun Rev (2006) 1.04
European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres. Ann Rheum Dis (2001) 1.04
Parotid sialography and minor salivary gland biopsy in the diagnosis of Sjögren's syndrome. A comparative study of 84 patients. J Rheumatol (1988) 1.03
A first study of cytokine genomic polymorphisms in CFS: Positive association of TNF-857 and IFNgamma 874 rare alleles. Clin Exp Rheumatol (2006) 1.03
HCV infection: pathogenesis, clinical manifestations and therapy. Clin Exp Rheumatol (2008) 1.03
Multicenter validation of recombinant, natural and synthetic antigens used in a single multiparameter assay for the detection of specific anti-nuclear autoantibodies in connective tissue disorders. Clin Exp Rheumatol (1999) 1.02
Impact of fibroblast growth factor-2 on tumor microvascular architecture. A tridimensional morphometric study. Am J Pathol (1998) 1.02
The validity of the ECLAM index for the retrospective evaluation of disease activity in systemic lupus erythematosus. Lupus (2000) 1.02
Non-Hodgkin's lymphoma: possible role of hepatitis C virus. JAMA (1994) 1.01
European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. IV. Assessment of skin thickening by modified Rodnan skin score. Ann Rheum Dis (2003) 1.01
Surface expression of a glycolytic enzyme, alpha-enolase, recognized by autoantibodies in connective tissue disorders. Eur J Immunol (2000) 1.01
An immunoglobulin light chain from a lupus-prone mouse induces autoantibodies in normal mice. J Exp Med (1990) 1.01
Gene polymorphism affecting alpha1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk. Ann Neurol (2000) 1.00
CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis--a longitudinal study. Rheumatology (Oxford) (2008) 1.00
The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis. Ann Rheum Dis (2008) 0.99
Erythema nodosum associated with pregnancy and oral contraceptives. Br Med J (1977) 0.99
Measuring functional disability in early rheumatoid arthritis: the validity, reliability and responsiveness of the Recent-Onset Arthritis Disability (ROAD) index. Clin Exp Rheumatol (2005) 0.99